By Sandy Still

Drug diversion in healthcare settings remains a persistent challenge. While technology has significantly improved diversion monitoring capabilities, one critical piece of evidence has largely remained siloed in electronic medical records: pain scores. 

Integrating this data into automated diversion surveillance workflows allows investigators to validate whether medications administered at the bedside match what patients actually experienced. But pain scores are only one part of the picture. Looking at pain score data alongside how providers manage pain medications provides investigators more context when evaluating diversion risk.

The gap between administration and outcome

Consider a common scenario. A patient’s chart shows persistently high or escalating pain scores, despite scheduled opioid doses being documented as administered. For diversion investigators, this clinical inconsistency often requires manual chart reviews or may go undetected altogether. Most diversion monitoring solutions capture medication dispensing and administration records, but may not incorporate the pain scores into the same investigation workflow.

Identifying this potential mismatch requires leaving the monitoring platform, opening the EMR, and manually cross-referencing the patient chart alongside flagged transactions. Without pain score data in a single view alongside medication administrations, investigators may miss an important clinical signal — patients continuing to report significant pain despite documented administration of opioid medication. 

What pain scores reveal

Pain scores bring important context into a diversion investigation. They help validate the clinical appropriateness of pain medications administered to patients. 

When a provider’s pain medication administration pattern appears unusual, pain score data may clarify whether the patient’s reported pain supports or contradicts that pattern. Escalating opioid doses alongside consistently low pain scores raises different questions than the same escalation alongside rising pain scores. 

Second, pain scores can expose noncompliance with documentation requirements. If a provider consistently administers controlled substances but rarely documents corresponding pain assessments, it may signal shortcuts in the clinical process or attempts to obscure diversion activity.

Spotting these patterns manually requires an investigator to know what to look for before the pattern becomes apparent. That becomes increasingly difficult when concerning behavior develops gradually.

From integration to analysis

The opportunity goes beyond just collecting pain score data. Surfacing pain scores at the exact moment an investigator needs them, and analyzing how providers handle pain medications relative to a patient’s baseline, are the next steps in identifying diversion risk. If pain scores are visible alongside dispense and administration records in the same view, investigators can see the patient’s clinical picture without disrupting their workflow. 

Pain medication pattern analysis is another signal that can help identify diversion risk. How providers handle pain medications compared to a patient’s baseline can help flag unusual behavior. For example, a dose increase that would be unremarkable for one patient can be flagged as an outlier for another because it’s inconsistent with that patient’s individual pattern. Pain scores recorded in the surrounding time window are surfaced alongside the flag, giving investigators the context for why a change may (or may not) be clinically justified.

Compliance and quality implications

Pain score visibility also supports broader compliance monitoring efforts. Healthcare organizations must verify that providers document pain assessments in accordance with their policies and that pain management protocols are followed consistently across units. 

Administration of pain medications should align with clinical need. Patient complaints about inadequate pain control or unrelieved pain, particularly when associated with specific staff members, are a recognized warning sign of possible diversion. Systematic pain score monitoring could surface these patterns before they reach the complaint stage.

Building defensible cases

Diversion investigations carry serious consequences. It is critical to have strong evidence to support or rule out diversion. Pain score documentation can strengthen a defensible diversion case by providing corroborating evidence that a medication may not have been administered as documented, particularly when the documented pain assessments are inconsistent with medication administration patterns.

Pain score data, coupled with pain medication pattern analysis, provides additional evidence that either supports or refutes diversion concerns. It helps investigators build cases they can stand behind or close as false positives.

Moving forward

As diversion monitoring evolves, investigators need a more complete picture of what is happening at the bedside when pain medications are administered. Patterns in how providers handle pain medications become more meaningful when evaluated alongside documented pain scores. Bringing that information into the investigation gives diversion teams another way to understand what happened at the bedside.

The future of diversion surveillance goes beyond collecting more data. The goal is to bring the right data into the investigation in a way that allows investigators to identify patterns earlier, rule out false positives, and build stronger cases when concerns warrant further investigation.